Stocks/BFAM

BFAM three-lens brief

Evidence-based stock research on BFAM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$57.63$64.27$114.32

Performance

1W
-9.6%
1M
-10.1%
3M
6M
YTD
1Y
3Y
5Y
BFAM · Nightly brief
Concern

Moved -2.41% yesterday. · Trading at 12% of its 52-week range — deep in the lower band.

  • Moved -2.41% yesterday.
  • Trading at 12% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • RSI at 27 — technically oversold.
  • Underperforming SPY by 26.2pp over 30 days.

BFAM closed at $64.27 (-2.41%) as of 2026-09-11. Market cap: $3.13B. P/E (trailing) 20.9. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $89.44 — 39% above current (9 analysts).. Concerns: moved -2.41% yesterday.; trading at 12% of its 52-week range — deep in the lower band.. Last quarter: Revenue $779.18M, net income $40.63M, free cash flow $240.15M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on BFAM, not one.

A single reasoning model has blind spots it doesn’t know about. We examine BFAMacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/BFAM"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath BFAM brief"></iframe>